Waltham, Mass.-based GeNO LLC is hoping to raise as much as $50 million through an initial public offering, with funds slated to further development and commercialization of the company’s GeNOsyl drug delivery technology.
New Jersey critical care devices maker Ikaria Inc. is rumored to be looking for an exit, hoping to claim at least $2 billion, according to unnamed sources.
Ikaria is owned by private equity and venture capital companies including Mountain Capital LLC, ARCH Venture Partners LP and Venrock Associates LP.
PSDV shares hit $3.96 each today, a 52-week high, having gained some 15.5% since a blogger writing as "Bob’s Stocks" published the rumor yesterday.
Ocular Therapeutix wrapped up patient enrollment for a Phase II trial evaluating the company’s OTX-DP tear duct plug, the company announced this week.